Radiation therapy methods

Details Radiation therapy methods Radiation therapy methods

2007-02-06

2007-02-06

Borin, Michael (Department: 1631)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S017400, C530S328000, C530S329000

Reexamination Certificate

active

10341001

ABSTRACT:
The present invention provides methods and kits for mitigating radiation induced tissue damage, improving the effectiveness of radiation therapy, to support bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production, each method comprising the administration of an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2type 2 receptor agonists.

REFERENCES:
patent: 5015629 (1991-05-01), DiZerega
patent: 5155211 (1992-10-01), Rosenberg
patent: 5178856 (1993-01-01), Burstein
patent: 5186931 (1993-02-01), Kishimoto et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5599712 (1997-02-01), Greenberger et al.
patent: 5616561 (1997-04-01), Barcellos-Hoff
patent: 5629292 (1997-05-01), Rodgers et al.
patent: 5693616 (1997-12-01), Krstenansky et al.
patent: 5716935 (1998-02-01), Rodgers et al.
patent: 5955430 (1999-09-01), Rodgers et al.
patent: 6239109 (2001-05-01), Rodgers et al.
patent: 6248587 (2001-06-01), Rodgers et al.
patent: 6335195 (2002-01-01), Rodgers et al.
patent: 6455500 (2002-09-01), Rodgers et al.
patent: 6475988 (2002-11-01), Rodgers et al.
patent: 6566335 (2003-05-01), Rodgers et al.
patent: 6747008 (2004-06-01), Rodgers et al.
patent: 6821953 (2004-11-01), Rodgers et al.
patent: 0 265 400 (1987-08-01), None
patent: WO 95/08337 (1995-03-01), None
patent: WO 95/08565 (1995-03-01), None
patent: WO 96/93164 (1996-12-01), None
patent: WO 97 34627 (1997-09-01), None
T. Kato, et al., “New Modality of Radiation Therapy Under Increased Tumor Oxygen Tension with Angiotensin II: A Pilot Study,” Radiation Medicine, vol. 11, No. 3, 1993, pp. 86-90.
Katrina Bedecs, Nathalie Elbaz, Malene Sutren, Maryline Mason, Christiane Susin, A. Donny Strosberg, Clara Nahmias, “Angiotensin II Type 2 Receptors Mediate Inhibition of Mitogen-Activated Protein Kinase Cascade and Functional Activation of SHP-1 Tyrosine Phosphatase,” Biochem. J., vol. 325, (1997) pp. 449-454.
Leonard Bell and Joseph A. Madri, “Influence of the Angiotensin System on Endothelial and Smooth Muscle Cell Migration,” American Journal of Pathology, vol. 137, No. 1, (1990) pp. 7-12.
Bradford C. Berk, Vladimir Vekshtein, Helen M. Gordon, Terutaka Tsuda, “Angiotensin II-Simulated Protein Synthesis in Cultured Vascular Smooth Muscle Cells,” Hypertension, vol. 13 (1989) pp. 305-314.
Arthur E. Bogden, Patrice Carde, Evelyne Deschamps de Paillette, Jacques-Pierre Moreau, Maurice Tubiana and Emilia Frindel, “Amelioration of Chemotherapy-Induced Toxicity by Co-treatment with AcSDKP, A Tetrapeptide Inhibitor of Hematopoietic Stem Cell Proliferation,” Annual N.Y. Acad. Sci. vol. 628 (1991) pp. 126-139.
Susan E. Bryson, Philip Warburton, Helen P. Wintersgill, G. Michael Drew, Anton D. Michel, Stephen G. Ball and Anthony J. Balmforth, “Induction of the Angiotensin AT2Receptor Subtype Expression by Differentiation of the Neuroblastoma x Glioma Hybrid, NG-108-15,” European Journal of Pharmacology, vol. 225 (1992) 119-127.
Rose-Marie Catalioto, Anna-Rita Renzetti, Marco Criscuoli, Jacques Mizrahi, Alessandro Subissi, “Angiotensins Induce the Release of Prostacyclin from Rabbit Vas Deferens: Evidence for Receptor Heterogeneity,” European Journal of Pharmacology, vol. 256 (1994) 93-97.
Eric P. Cohen, Angostino Molteni, Patricia Hill, Brian L. Fish, William F. Ward, John E. Moulder and Frank A. Carone, Captopril Preserves Function and Ultrastructure in Experimental Radiation Nephropathy, Laboratory Investigation, vol. 75, No. 3 (1996), pp. 349-360.
Eric p. Cohen, John E. Moulder, Brian L. Fish ad Patricia Hill, “Prophylaxis of Experimental Bone Marrow Transplant Nephropathy,” J. Lab. Clin. Med., vol. 124 (1994) pp. 371-380.
Eric P. Cohen, Brian L. Fish and John E. Moulder, “Successful Brief Captopril Treatment in Experimental Radiation Nephropathy,” J. Lab Clin. Med., vol. 129 (1997) pp. 536-547.
H,J. Deeg, K. Seidel, D.S. Hong, C. Yu, R. Huss, F.G. Schuening, C.H. Ewel and R. Storb, “In Vivo Radioprotective Effect of AcSDKP on Canine Myelopoiesis,” Ann. Hematology, vol. 74 (1997) pp. 117-122.
David J. Dunlop, Eric G. Wright, Sally Lorimore, Gerard J. Graham, Tessa Holyoake, David J. Kerr, Stephen D. Wolpe and Ian B. Pargness, “Demonstration of Stem Cell Inhibition Myeloprotective Effects of SCI/rhMIP1α In Vivo,” Blood, vol. 79, No. 9 (1992) pp. 2221-2225.
Victor E. Dzau, Richard Pratt, Gary Gibbons, Heribert Schunkert, Beverly Lorell and Julie Ingelfinger, “Molecular Mechanism of Angiotensin in the Regulation of Vascular and Cardiac Growth,” J. Mol. Cell. Cardiol., vol. 21 (Supplemental III) (1989) p. S.7.
Richard M. Edwards and Elwood J. Stack, “Angiotensin II Inhibitors Glomerular Adenylate Cyclase via the Angiotensin II Receptor Subtype 1 (AT1),” The Journal of Pharmacology and Experimental Therapeutics, vol. 266, No. 2 (1993) pp. 506-510.
Leonardo A. Fernandez, Jeff Twickler and Alden Mead, “Neovascularization Produced by Angiotensin II,” vol. 105, No. 2 (1985) pp. 141-145.
J. P. Geraci, M-C. Sun and M.S. Mariano, “Amelioration of Radiation Nephropathy in Rats by Post-Radiation Treatment with Dexamethasone and/or Captopril,” Radiation Research, vol. 143 (1995) pp. 58-68.
Neelam Jaiswal, E. Ann Tallant, Debra I. Diz, Mahesh C. Khosla and Carlos M. Ferrario, “Subtype 2 Angiotensin Receptors Mediate Prostaglandin Synthesis in Human Astrocytes,” Hypertension, vol. 17 (1991) pp. 1115-1120.
Neelam Jaiswal, E. Ann Tallant, Rama K. Jaiswal, Debra I. Diz and Carlos M. Ferrarion, “Differential Regulation of Prostaglandin Synthesis by Angiotensin Peptides in Porcine Aortic Smooth Muscle Cells: Subtypes of Angiotensin Receptors Involved,” the Journal of Pharmacology and Experimental therapeutics, vol. 266, No. 2 (1991) pp. 664-673.
Neelam Jaiswal, Debra I. Diz, Mark C. Chappell, Mahesh C. Khosla and Carlos M. Ferrario, “Stimulation of Endothelial Cell Prostaglandin Production by Angiotensin Peptides,” Hypertension, (Supplemental II) (1992) II-49-II-55).
Philip Janiak, Aline Pilon, Jean-Francois Prost and jean-Paul Vilaine, “Role of Angiotensin Subtype 2 Receptor in Neointima Formation After Vascular Injury,” Hypertension, vol. 20 (1992) pp. 737-745.
Toshio Kato, Yuko Murakami, Yutaka Saito, Noriaki Tomura, Masaaki Shindo, Jiro Watarai and Yoshiharu Tamakawa, new Modality of Radiation Therapy Under Increased Tumor Oxygen Tension with Angiotensin II: A Pilot Study, Radiation medicine, vol. 11, No. 3 (1993) pp. 86-91.
Raymond F. Kauffman, James S. Bean, Karen M. Zimmerman, Raymond F. Brown, and Mitchell I. Steinberg, “Losartan, A Nonpeptide Angiotensin II (ANG II) Receptor Antagonist, Inhibits Neointima Formation Following Balloon Injury To Rat Cartoid Arteries,” Life Sciences, vol. 49, (1991) pp. 223-228.
Yasuhiro Kawahara, Michitoshi Sunako, Terutaka Tsuda, Hisashi Fukuzaki, Yasuo Fukumoto and Yoshimi Takai, “Angiotensin II Induces Expression of the C-fos Gene Through Protein Kinase C. Activation and Calcium Ion Mobilization in Cultured Vascular Smooth Muscle Cells,” Biochemical and Biophysical Research Communication, vol. 150, No. 1 (1988) pp. 52-59.
Birgitta Kimura, Colin Sumners and M. Ian Philllips, “Changes in Skin Angiotensin II Receptors in Rats During Wound Healing,” Biochemical and Biophysical Research Communication, vol. 187, No. 2 (1992) pp. 1083-1090.
Ferdinand A.C. Le Noble, Johan W.M. Hekking, Henny W. M. Van Straaten, Dick W. Slaff, and Harry A.J. Struyker Boudier, “Angiotensin II Stimulates Angiotensins in the Chorio-Allantoic Membrane of the Chick Embryo,” European Journal of Pharmacology, vol. 195 (1991) pp. 305-306.
A. Masse, L.H. Ramirez, G. Bindoula, C. Grillon, J. Wdzieczak-Bakala, K. Raddassi, E. Deschamps de Paillette,

Affiliated with

Also associated with

Rating

Radiation therapy methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radiation therapy methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiation therapy methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3835012